Clinical Trials Logo

Filter by:
NCT ID: NCT04717505 Completed - Rheumatic Diseases Clinical Trials

Dual Task Performance in Rheumatic Diseases

Start date: November 1, 2020
Phase:
Study type: Observational

Chronic pain is pain that exceeds the duration of the injury or trigger stimulus and lasts for at least three months. Recent studies show that chronic pain has devastating effects on cognitive functions by causing emotional stress, anxiety, and depression.The studies show that chronic pain affects certain cognitive areas. These areas are; processing speed, short-term memory, longterm memory, inhibitory control and working memory. In addition, task-oriented studies show that chronic pain affects not single tasks, but rather dual tasks that require the use of complex cognitive function (executive function). 40-60% of rheumatologic patients do not have sufficient relief in their pain. For this reason, dual task performance may be affected in individuals diagnosed with rheumatological disease, secondary to the impairment of cognition. In the literature, there are only limited studies showing dual-task performance effects in individuals diagnosed with fibromyalgia and osteoarthritis. However, chronic pain is the main health problem that prevents mobility restriction and participation in all rheumatic diseases. In addition, there is no study investigating the dual task performance effect in rheumatic diseases in a comprehensive way. Therefore, the aim of the study is to investigate the effect of rheumatic diseases on dual-task performance by comparing it with the control group.

NCT ID: NCT04716855 Completed - Clinical trials for Rotator Cuff Syndrome

Evaluation of Functional Status, Physical Activity and Quality of Life in Patients With Rotator Cuff Syndrome

Start date: March 25, 2015
Phase:
Study type: Observational [Patient Registry]

Pain is one of the most important factors affecting the quality of life. The quality of life of patients with pain and restricted shoulder movements can be affected in patients with Rotator Cuff Syndrome (RCS).

NCT ID: NCT04716842 Active, not recruiting - Sepsis Clinical Trials

Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.

Start date: January 1, 2021
Phase:
Study type: Observational

Evaluation of plasma angiotensin II and angiotensin II receptor levels in patients with sepsis and septic shock: a prospective observational study.

NCT ID: NCT04716764 Recruiting - Breast Cancer Clinical Trials

Dietary Advanced Glycation End Products, Inflammation and Oxidative Stress in Breast Cancer Patients

Start date: March 3, 2020
Phase:
Study type: Observational

Breast cancer is among the most common types of cancer in the world. Factors such as age, reproduction, nutrition, hormonal, and lifestyle factors also play a role in the etiology of breast cancer. Nutrition can affect cancer metabolism at stages such as carcinogen metabolism, cell, and host defense, cell differentiation, and tumor growth. When investigating nutrition and breast cancer risk, it is important to evaluate the preparation and cooking processes applied to foods. Advanced glycation end products (AGE) are formed as a result of heat treatment applied to foods. There are studies showing that AGEs increase inflammation and oxidative stress in the organism. It is aimed to compare the dietary AGE intake and serum levels of AGE participants with breast cancer and healthy participants and to examine the relationship with serum inflammatory, oxidative stress, DNA damage, and total antioxidant capacity. Patients with breast cancer will be evaluated before surgery, before chemotherapy, and in the sixth and twelfth months after starting chemotherapy. The amount the dietary AGE intake, serum markers, nutritional status, and changes in quality of life will be determined.

NCT ID: NCT04716530 Recruiting - Cerebral Palsy Clinical Trials

The Changing Panorama in Risk Factors of Cerebral Palsy

Start date: January 15, 2021
Phase:
Study type: Observational

The study will be carried of scanning the database of 296 individuals with cerebral palsy followed in the university pediatric rehabilitation clinic. Cerebral palsy risk factors and demographic information will be obtained from the database. The data will be classified according to date of birth, divided into 3 groups: those born before 2000, those born between 2000-2010, and those born after 2010.Changes in cerebral palsy risk factors will be investigated at 10-year intervals.

NCT ID: NCT04715919 Completed - Covid19 Clinical Trials

Long Term Outcomes of Coronavirus Disease-19 (COVID-19)

Start date: January 15, 2021
Phase:
Study type: Observational

The investigators hypothese that lung involvement due to COVID-19 may cause structural changes in the lung in the long term. In this study the effects of structural changes in the lung on pulmonary function tests, exercise capacity and quality of life will be examined.

NCT ID: NCT04715477 Recruiting - Anxiety Clinical Trials

Intensive Care Anxiety in SARS-CoV-2 Patients

Start date: January 17, 2021
Phase:
Study type: Observational

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

NCT ID: NCT04714931 Recruiting - Ovarian Cancer Clinical Trials

Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5)

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The aim of the study to evaluate the feasibility and accuracy of sentinel lymph node technique in ovarian cancer.

NCT ID: NCT04714775 Recruiting - Asphyxia Neonatorum Clinical Trials

Biomarkers And Neurological Outcome in Neonates 2

BANON2
Start date: February 5, 2019
Phase:
Study type: Observational

Follow-up of participants of BANON1 study at age of at least 2 years. BANON1 (ClinicalTrials.gov ID: NCT03357250): Validation of biomarkers based on 24 months neuro-developmental outcome data in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies and a preliminary human study.

NCT ID: NCT04714502 Active, not recruiting - Birth Asphyxia Clinical Trials

Asphyxia Associated Metabolite Biomarker Investigation 2

AAMBI2
Start date: July 2, 2019
Phase:
Study type: Observational

Follow-up of participants of AAMBI1 study at age of at least 2 years. AAMBI1(ClinicalTrials.gov ID: NCT03354208): Verification of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies.